[PDF][PDF] The complexities of biosimilars and the regulatory approval process
S Lucio - Am J Manag Care, 2018 - ajmc.s3.amazonaws.com
The potential for a biosimilar class of drugs came into existence via the Biologics Price
Competition and Innovation Act (BPCIA) of 2009, itself a part of the Patient Protection and …
Competition and Innovation Act (BPCIA) of 2009, itself a part of the Patient Protection and …
The complexities of biosimilars and the regulatory approval process
S Lucio - The American journal of managed care, 2018 - pubmed.ncbi.nlm.nih.gov
Created via the Biologics Price Competition and Innovation Act, the biosimilar class of drugs
was conceived as an opportunity to introduce competition for commonly used biologics …
was conceived as an opportunity to introduce competition for commonly used biologics …
The complexities of biosimilars and the regulatory approval process.
S Lucio - The American Journal of Managed Care, 2018 - europepmc.org
Created via the Biologics Price Competition and Innovation Act, the biosimilar class of drugs
was conceived as an opportunity to introduce competition for commonly used biologics …
was conceived as an opportunity to introduce competition for commonly used biologics …